This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
A look at pending data update from ATA188 and potential in multiple sclerosis.
Ticker(s): ATRAWho's the expert?
Institution: University of Ottawa
- Professor of Medicine at the University of Ottawa, as well as director of the Multiple Sclerosis Research unit at the Ottawa Hospital
- Extensive research includes the area of molecular neurochemistry, cellular immunology, neuroimmunology cell-based therapeutics and clinical studies in MS
- Over 35 years of experience in the treatment of patients with MS.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
